Avadel Pharmaceuticals Ownership | Who Owns Avadel Pharmaceuticals?
Avadel Pharmaceuticals Ownership Summary
Avadel Pharmaceuticals is owned by 83.40% institutional investors, 4.89% insiders, and 11.72% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 7.04% of AVDL shares. Polar Capital Healthcare Opports Inc is the top mutual fund, with 3.81% of its assets in Avadel Pharmaceuticals shares.
AVDL Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Avadel Pharmaceuticals | 83.40% | 4.89% | 11.72% |
Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 43.51% | 11.55% | 44.95% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Blackrock funding, inc. /de | 6.80M | 7.04% | $60.21M |
Brandes investment partners, lp | 6.49M | 6.72% | $57.42M |
Two seas capital lp | 6.16M | 6.37% | $54.47M |
Gendell jeffrey l | 5.18M | 5.36% | $45.81M |
Polar capital | 4.00M | 4.14% | $35.39M |
Vivo capital | 2.68M | 2.78% | $23.75M |
Wealth effects | 2.35M | 2.44% | $20.84M |
Tang capital management | 2.10M | 2.17% | $18.56M |
Kennedy capital management | 981.27K | 1.02% | $8.68M |
Krensavage asset management | 958.88K | 0.99% | $8.49M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Wealth effects | 2.35M | 7.80% | $20.84M |
Knoll capital management | 600.00K | 5.68% | $8.44M |
Krensavage asset management | 958.88K | 4.49% | $8.49M |
Vivo capital | 2.68M | 2.43% | $23.75M |
Knott david m jr | 426.00K | 1.71% | $3.77M |
Samsara biocapital | 675.50K | 1.22% | $5.98M |
Gendell jeffrey l | 5.18M | 1.22% | $45.81M |
Tang capital management | 2.10M | 0.94% | $18.56M |
Two seas capital lp | 6.16M | 0.91% | $54.47M |
Iridian asset management llc/ct | 249.59K | 0.77% | $2.21M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock funding, inc. /de | 6.80M | 0.00% | 1.35M |
Two seas capital lp | 6.16M | 0.91% | 1.21M |
Brandes investment partners, lp | 6.49M | 0.52% | 820.47K |
Invenomic capital management lp | 802.99K | 0.40% | 574.97K |
Awm investment company | 316.19K | 0.31% | 275.19K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Janus henderson group | - | - | -12.92M |
Rtw investments, lp | - | - | -8.80M |
Braidwell lp | - | - | -4.11M |
Tri locum partners lp | - | - | -1.94M |
Adage capital partners gp | - | - | -1.91M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Jump financial | 138.95K | 0.01% | 138.95K | $1.23M |
Qube research | 119.96K | 0.00% | 119.96K | $1.06M |
Y-intercept (hong kong) | 95.85K | 0.02% | 95.85K | $848.27K |
Los angeles capital management | 79.11K | 0.00% | 79.11K | $700.16K |
Summit financial | 69.23K | 0.01% | 69.23K | $612.70K |
Sold Out
Holder | Change |
---|---|
Principal securities | -9.00 |
Zurcher kantonalbank (zurich cantonalbank) | -19.00 |
Signaturefd | -22.00 |
Stephens consulting | -45.00 |
Fortitude family office | -55.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 173 | -6.99% | 80,562,728 | 4.59% | 83 | 1.31% | 92 | -7.07% | 48 | -2.04% |
Mar 31, 2025 | 185 | 5.71% | 77,012,100 | -3.02% | 79 | 1.17% | 99 | 11.24% | 48 | 6.67% |
Dec 31, 2024 | 2 | -60.00% | 137,001 | -87.20% | - | 11.52% | - | - | - | -100.00% |
Sep 30, 2024 | 5 | -50.00% | 1,070,001 | -84.77% | 1 | 1.89% | - | -100.00% | 1 | - |
Jun 30, 2024 | 10 | -92.42% | 7,025,014 | -89.75% | 7 | 0.10% | 3 | -96.05% | 1 | -96.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Polar Capital Healthcare Opports Inc | 3.69M | 3.81% | - |
Vanguard US Total Market Shares ETF | 2.99M | 3.09% | - |
Vanguard Total Stock Mkt Idx Inv | 2.87M | 2.97% | -63.75K |
Janus Henderson Global Life Sciences D | 2.27M | 2.35% | -178.86K |
Janus Henderson Global Life Sciences | 2.27M | 2.35% | -207.97K |
iShares Russell 2000 ETF | 2.15M | 2.21% | - |
Janus Global Life Science AUSD | 1.89M | 1.95% | -131.51K |
Janus Henderson Glb Life Scn I2 USD | 1.72M | 1.78% | -159.56K |
Polar Capital Biotech S Inc | 1.50M | 1.56% | - |
Janus Henderson US Small Cap Growth MA | 1.48M | 1.54% | 1.48M |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 21, 2025 | Palczuk Linda | - | Buy | $39.64K |
Jan 13, 2025 | Thornton Peter J. | - | Buy | $80.45K |
Jan 13, 2025 | Ende Eric J | - | Buy | $235.22K |
Dec 13, 2024 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $24.02K |
Dec 11, 2024 | MCHUGH THOMAS S | Chief Financial Officer | Buy | $52.43K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | 3 | - |
2024 Q4 | 7 | - |
2024 Q3 | - | - |
AVDL Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools